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Accepted 30 October 2012; Published online 8 February 2013AbstractObjectives: Adjustment for morbidity is important to ensure fair comparison of outcomes between patient groups and health care pro-
viders. The Quality and Outcomes Framework (QOF) in UK primary care offers potential for developing a standardized morbidity score for
low-risk populations.
Study Design and Setting: Retrospective cohort study of 653,780 patients aged 60 years or older registered with 375 practices in 2008
in a large primary care database (The Health Improvement Network). Half the practices were randomly selected to derive a morbidity score
predicting 1-year mortality; the others assessed predictive performance.
Results: Nine chronic conditions were robust copredictors (hazard ratio51.2) of mortality independent of age and sex, producing
high predictive discrimination (c-statistic5 0.82). An individual’s QOF score explained more between practice variation in mortality than
the Charlson index (46% vs. 32%). At practice level, mean QOF score was strongly correlated with practice standardized mortality ratios
(r5 0.64), explaining more variation in practice death rates than the Charlson index.
Conclusion: A simple nine-item score derived from routine primary care recording provides a morbidity index highly predictive of
mortality and between practice variation in older UK primary care populations. This has utility in research and health care outcome mon-
itoring and can be easily implemented in other primary and ambulatory care settings.
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Comorbidity is an important concept in clinical care, re-
search, and health service outcome monitoring, and ap-
proaches to measuring morbidity levels need to be simple
and standardized [1]. Morbidity scores, designed to sum-
marize comorbidity for individual patients, by summing
scores for selected diseases, are widely used in research
and service monitoring to adjust for baseline differences
in patient groups or service providers [2]. In primary and
ambulatory care, robust adjustment for case mix is impor-
tant for valid interpretation of both observational research
and routine health services outcome data [3]. A range of
morbidity scores have been used, of which the Charlson in-
dex is the most well known [4]. It was developed in the
United States in the 1980s to predict 1-year mortality, based
on a list of common chronic conditions, and has been* Corresponding author. Tel.: þ44-208-725-0066; fax: þ44-208-725-
3584.
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Open access under CC BY-NC-ND license.validated in many different groups of patients worldwide
[2,5e8]. It has been widely used in research with primary
care data [9e11] despite it being derived from secondary
care data. Implementation in primary and ambulatory care
settings presents a number of challenges including agree-
ment on appropriate code lists and quality of recording
[12]. The only comorbidity score developed in ambulatory
care settings is the Johns Hopkins adjusted clinical group
system, which is limited by its complexity and data require-
ments in comparison with the Charlson Index.
The UK Quality and Outcomes Framework (QOF) was
introduced into primary care in 2004 [13]. It aimed to im-
prove chronic disease management by remunerating general
practitioners for achieving clinical targets. It offers the op-
portunity to use routinely collected data, with standardized
definitions for disease coding, to develop a simple novel
morbidity score for primary care [14]. Use of QOF-based
morbidity measures has a number of potential advantages,
including inclusion of a range of conditions managed in
primary care, such as severe mental illness and epilepsy,
and better performance in low-risk community settings.
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 Standardized measurement of morbidity is impor-
tant, but few morbidity scores have been developed
in primary or ambulatory care settings.
 A simple score derived from routinely recorded
chronic conditions in primary care is highly predic-
tive of 1-year mortality in an older UK population.
 It is more effective in explaining differences in
mortality between practices than the established
Charlson index.
 Morbidity levels also explain more interpractice
variation in mortality than measures of deprivation.
 This new score offers the potential for improving
risk-adjusted comparisons of performance and out-
comes between primary care providers.Specifically in the United Kingdom, it offers ease of appli-
cation in nonresearch settings including national monitor-
ing of general practice outcomes such as mortality. In this
article, we describe the use of QOF data from UK primary
care to create a simple morbidity score for older people and
report on its effectiveness in predicting mortality, and ex-
plaining between practice variation, in comparison to the
established Charlson index.2. Methods
2.1. Data source
The Health Improvement Network (THIN) database is
an established primary care database, which collects anony-
mized data from participating UK general practices, which
use the Vision practice computer system [15]. As of 2010, it
comprised 3.6 million active patients, 5.8% of the UK pop-
ulation. It includes a full longitudinal record of registration,
consultation, diagnosis, and prescribing.
2.2. Subjects
Our analysis is based on patients aged 60 years and older
included in a study of bereavement, mortality, and comorbid-
ity in older people [16]. We included 375 practices that pro-
vided data for at least 1 year after a practice index date in
2008. This identified 653,780 patients aged 60 and older reg-
istered in the THIN database on the index date. For internal
validation of our morbidity score, we divided the practices
into two groups. Half the practices (n5 188) were randomly
selected to be used as a ‘‘training’’ set, which was used to de-
rive a ‘‘QOFmorbidity score.’’ The other half (n5 187)were
then used as a ‘‘validation’’ set to assess model performance.2.3. Main outcome
Patients were followed for 1 calendar year. Date of death
was identified through a record of death in the primary care
record [17], either by a relevant deregistration flag or spe-
cific Read codes. Patients who deregistered alive from their
practice were censored from the analysis on their date of
deregistration.
2.4. Identifying morbidity
We identified recorded chronic disease prevalence at
baseline in 2008 by using the QOF disease definitions from
the UK general practice contract, which are used to deter-
mine practice payments [13]. We applied the definitions for
published national disease prevalence for 15 of 18 condi-
tions, excluding obesity, learning disability, and palliative
care. As per definition, cancer was restricted to diagnoses
in the last 5 years, whereas asthma, epilepsy, and hyperthy-
roidism all required additional recent prescription of relevant
medication. We refer to these morbidities as ‘‘Standard
QOF.’’ A list of the Read codes for these conditions, and their
mapping to International Classification of Diseases (ICD-
10), is provided in the Appendix at www.jclinepi.com.
We also investigated whether the proposed score could
be improved by identifying more severe subgroups of the
standard QOF conditions, so we developed an ‘‘extended
QOF’’ list of conditions. Specifically we (1) identified myo-
cardial infarction (MI) distinct from coronary heart disease
(CHD), (2) separated stroke from transient ischemic attack,
(3) subdivided chronic kidney disease into separate stages
(3, 4, or 5), (4) restricted depression to a diagnosis in the
last 12 months, and (5) subdivided cancer into metastatic
and nonmetastatic. MI and stroke are separately identified
in QOF for some disease indicators.
We also identified the existence at baseline of any mor-
bidities in the Charlson index. We initially used the Read
code list created by Khan et al. [9], but amended some of
their inclusions. We added to their lists any codes used by
QOF for the same condition, and removed any codes that
we judged were erroneously included (list available from au-
thors). For example for ‘‘Chronic Pulmonary Disease’’ we
did not include ‘‘Bronchitis unspecified’’ or ‘‘Chest infec-
tion,’’ which were on the Khan list but more likely to be used
for acute respiratory problems rather than chronic disease.
2.5. Prediction models of 1-year mortality
In the training set, a Cox proportional hazard model ad-
justing for age and sex was fitted to all conditions simulta-
neously. We then included conditions with a hazard ratio
(HR) of 1.2 or higher as predictors for the QOF score. Fol-
lowing other authors [4,7], we created a weighted additive
score based on the HRs (1 if HR5 1.2e1.5, 2 if
HR5 1.5e2.5, 3 if HR5 2.5e3.5, 4 if HR5 3.5e4.5, 5
if HR5 4.5e6.0, and 6 if HRO 6.0), but also considered
a score based on a count of the conditions only. The model
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estimator to produce robust standard errors and 95% confi-
dence intervals for the HRs is PROC PHREG in SAS
version 9.2 (SAS Institute, Inc., Cary, NC, USA).
In the validation set, c-statistics, a summary measure of
model discrimination, which is analogous to the area under
the receiver operator curve [18], were compared between
two QOF-derived morbidity scores (standard and extended)
and the Charlson index. These were calculated using
the stcox command in Stata version 10.1 (StataCorp LP,
College Station, TX, USA) [19].
2.6. Score utility in explaining variation between
practices and effect of adjustment for deprivation
Deprivation was measured using the Townsend Score
[20], a composite small area ecological measure of depriva-
tion, which was assigned to patients based on their postcode
and summarized as quintiles based on national ranking.
We estimated each score’s ability to explain differences
in 1-year mortality between practices in the validation set in
two ways. The first approach used a multilevel logistic
model with random intercepts fitted for practice (using
PROC GLIMMIX in SAS version 9.2). The estimated var-
iance of the practice intercepts, which gives an estimate of
the variability between practices, was compared between
models including each score at patient level and a model
adjusting only for age and sex. This was repeated including
deprivation in the model at the patient level.
The second approach is based on analyzing data in the val-
idation set summarized at practice level; the purpose is to il-
lustrate how an analysis based on routinely available data at
national level could be carried out. In this approach, we cal-
culated a mean practice score (per number of registered pa-
tients in the practice) for each morbidity score and for
deprivation. This was used to predict the log standardized
mortality ratio for each practice, which were indirectly stan-
dardized by age and sex to the overall population. To do this,
we performed a random effects meta-regression (using the
metareg command in Stata version 10.1). Each practice
was assigned a weight for its within practice standard error
or sampling error, estimated by 1/OO where O is the number
of observed deaths in the practice [21]. We again present the
reduction in the between practice variance accounted for by
inclusion of each of the practice morbidity scores in the
model. This approach estimates the real contribution of the
covariates to explaining differences between practices after
removing sampling variation [22].We did this with andwith-
out the average practice deprivation score.3. Results
3.1. Characteristics of sample
The 653,780 patients in our data set were divided into
training (n5 317,876) and validation sets (n5 335,904).The mean age (71.6 years) and gender profile (51.4%
women) were identical in the two sets. At 1 year, in the
training data set, 3.3% (10,595/317,876) had died, whereas
a further 2.6% (8,094/317,876) had left the practice for
a reason other than death. Identical rates of mortality
(11,201/335,9045 3.3%) and deregistration (8,857/
335,9045 2.6%) were seen in the validation set.3.2. Training model
Table 1 summarizes the results of fitting the standard and
extended QOF morbidities to the 317,876 patients in the
training data set. Of the 15 Standard QOF morbidities, nine
produced an HR of 1.2 or higher in a mutually adjusted
model with age and sex. Cancer (HR5 3.42) and dementia
(HR5 2.83) were the strongest predictors. The six morbid-
ities with HR lower than 1.2 (asthma, chronic kidney disease
[stages 3e5], depression, hypertension, hypothyroidism,
and CHD) were dropped from consideration for the standard
QOF score. However, for the extended score, subsets of
these conditions were included (chronic kidney disease stage
4 or 5, depression in last 12 months, and MI).
Table 2 shows the morbidities and weights for the stan-
dard QOF (9 conditions), extended QOF (14 conditions),
and the Charlson index (17 conditions). Standard QOF con-
ditions that do not appear in the Charlson index were atrial
fibrillation, epilepsy, and severe mental illness (psychosis,
schizophrenia, and bipolar affective disease). The standard
QOF score gave greater weight to dementia, chronic ob-
structive pulmonary disease, and heart failure than the
Charlson index.3.3. Validation model
The distribution of the three scores when applied to the
validation data set is shown in Table 3. The Charlson index
identified a higher proportion of patients with at least one
condition than the nine standard QOF conditions: 48%
(159,544/335,904) vs. 32% (107,478/335,904). This was
also true for multiple morbidities where 17% (57,576/
335,904) vs. 8% (27,698/335,904) had two or more condi-
tions. The main reason for the higher classification rates in
the Charlson index is the inclusion of any asthma, which
was dropped from the QOF scores as it does not predict
mortality. The Charlson index identified more high-risk pa-
tients: 0.13% (440/335,904) vs. 0.07% (242/335,904) had
a score of 8þ. However, this was no longer true in the ex-
tended QOF score where 0.26% (866/335,904) had a score
of 8þ.
The predictive performance of the morbidity scores is
summarized by the c-statistics in Table 3. A simple count
of the morbidities in each of the scores produced significant
improvement from a basic model adjusting for age and sex
(c-statistic5 0.81 vs. 0.78). Fitting the weighted score as
a nine-level variable further improved discrimination, with
the standard QOF score outperforming the Charlson index
Table 1. Prevalence and association with 1-yr mortality of standard and extended QOF conditions in training data set (n5 317,876)
Comorbidity Additional criteria
Percent of
patients
Standard QOF scorea Extended QOF scorea
Adjusted HRb 95% CI Adjusted HRb 95% CI
Asthma Treatment in last 12 mo 7.0 0.94 0.87e1.02 0.94 0.86e1.03
Atrial fibrillation 6.0 1.32 1.24e1.40 1.33 1.25e1.41
Cancer (excluding nonmelanotic
skin cancers)
Diagnosis O1 April 2003 4.7 3.42 3.19e3.67 d d
Metastatic Diagnosis O1 April 2003 0.16 d d 12.92 9.76e17.10
Nonmetastatic Diagnosis O1 April 2003 4.6 d d 3.14 2.92e3.38
Chronic kidney disease (stages)
3e5 14.7 1.13 1.07e1.19 d d
4 only 0.94 d d 1.73 1.55e1.93
5 only 0.14 d d 4.85 3.95e5.97
COPD 5.9 2.05 1.92e2.19 2.04 1.91e2.18
Coronary heart disease 15.1 1.17 1.12e1.22 d d
No myocardial infarction 9.5 d d 1.01 0.95e1.06
Myocardial infarction only 5.6 d d 1.44 1.35e1.53
Dementia 2.1 2.83 2.63e3.04 2.85 2.65e3.07
Depression 16.2 1.11 1.05e1.18 d d
Depression Diagnosis in last 12 mo 1.3 d d 1.27 1.09e1.49
Diabetes 11.6 1.37 1.31e1.44 1.35 1.28e1.43
Epilepsy Treatment in last 6 mo 1.0 1.64 1.39e1.92 1.63 1.39e1.91
Heart failure 3.3 1.79 1.68e1.91 1.75 1.63e1.87
Hypertension 43.7 0.90 0.87e0.94 0.91 0.87e0.94
Hypothyroidism Treatment in last 6 mo 8.1 0.99 0.93e1.05 0.99 0.93e1.05
Psychosis, schizophreniaþ bipolar
affective disorder
1.0 1.74 1.49e2.04 1.82 1.57e2.11
Stroke or TIA 7.4 1.33 1.27e1.40 d d
Stroke 4.2 d d 1.53 1.44e1.62
TIA (no stroke) 3.2 d d 1.10 1.01e1.20
Abbreviations: QOF, Quality and Outcomes Framework; HR, hazard ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease;
TIA, transient ischemic attack.
a Standard score considered 15 standard QOF conditions. Extended score included more detailed categorization of cancer (metastatic or not),
chronic kidney disease (stage 4 or 5), coronary heart disease (with or without myocardial infarction), depression (last 12 mo only), and stroke/TIA
(stroke and TIA separately).
b Adjusted for age, sex, and all morbidities listed in the column of the table, except those with a blank entry.
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QOF score produced only a modest improvement in overall
model performance (c-statistic5 0.829). An alternative
model using multiplicative weights based directly on the
HRs did not improve performance (data not shown). A sin-
gle point increase in the standard QOF score increased mor-
tality risk by 42%, roughly equivalent to a 4-year increase
in age in the model.3.4. Score utility in explaining variation between
practices and effect of adjustment for deprivation
The hierarchical logistic model suggested that both QOF
scores were more effective than the Charlson index in ex-
plaining practice variation in mortality (Table 4). The ad-
justment for the standard QOF score at patient level
reduced the estimated variance between practices by 46%
compared with 32% for the Charlson index.
At the practice level,meanmorbidity scores were strongly
correlated with age- and sex-standardized practice mortality
rates for all scores (Fig. 1) with the strongest association for
the QOF scores (r5 0.64). In the meta-regression, inclusion
of either QOF score both produced greater reductions in theestimate of the between practice variation (66% for standard
QOF score vs. 51% for Charlson index).
Additional adjustment for deprivation in both the indi-
vidual and practice models (Table 4) slightly reduced the
interpractice variation explained by the scores (e.g., 46 to
39% for individual QOF score); however, the QOF score re-
mained more effective at explaining this variation than the
Charlson index. Adjustment for deprivation instead of mor-
bidity score explained less interpractice variation than any
of the morbidity indices, for example 22% for the individ-
ual model (0.0330 to 0.0256; Table 4).4. Discussion
In this article, we have used routinely collected data in
UK primary care to construct a simple morbidity score that
is highly predictive of 1-year mortality. We have shown that
the discriminatory performance of the QOF score is equiv-
alent to that of the Charlson index. Furthermore, the score
at an individual and practice level was able to account for
a large proportion of interpractice variation in mortality,
even after adjustment for deprivation, and was more effec-
tive than the Charlson index in this regard.
Table 2. Scoring weights for QOF scores and Charlson index
Condition Gradation (if applicable)a Standard QOF Charlson index Extended QOF
Atrial fibrillation 1 d 1
AIDS d 6 d
Cancerb Nonmetastatic/metastatic 3 2/6 3/6
COPDc 2 1 2
Depression (last 12 mo) d d 1
Dementia 3 1 3
Diabetes Without/with complications 1 1/2 1
Epilepsy (treated) 2 d 2
Heart failure 2 1 2
Hemiplegia d 2 d
Liver disease Mild/moderate d 1/3 d
Myocardial infarction d 1 1
Peptic ulcer disease d 1 d
Peripheral vascular disease d 1 d
Psychosis, schizophreniaþ bipolar affective disorder 2 d 2
Renal disease Stage 4/5 d 2 2/5
Rheumatological disease d 1 d
Stroke or TIA TIA only/stroke 1 1 0/2
Abbreviations: QOF, Quality and Outcomes Framework; AIDS, acquired immunodeficiency syndrome; COPD, chronic obstructive pulmonary dis-
ease; TIA, transient ischemic attack.
a Where subgroups are identified within a condition, score assigned is dependent on severity.
b QOF cancer is defined as diagnoses after 1 April 2003 and excludes all skin cancers.
c COPD definition in Charlson index includes asthma.
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The main strength of our approach is that the QOF score
is relatively simple to implement and based on routinely
collected data on occurrence of common chronic condi-
tions. Some proposed morbidity scores include 30 [23],
70 [24], or more than 100 [25] separate items and may
not be as easily applied. Similarly the Johns Hopkins
case-mix system [26] has several layers of complexity
and requires a license for its use. By contrast, chronic con-
ditions included in our QOF score are likely to be well re-
corded in primary care or amenable to simple collection.Table 3. Performance of morbidity scores predicting 1-year mortality in vali
Score
Standard QOF score Cha
% Patients HR 95% CI % Patients
Zero score 68.0 1 d 52.5
1 vs. 0 14.1 1.72 1.62e1.82 23.0
2 vs. 0 7.4 2.70 2.54e2.88 14.0
3 vs. 0 6.7 4.41 4.15e4.67 6.1
4 vs. 0 2.2 5.10 4.71e5.53 2.5
5 vs. 0 1.0 6.13 5.56e6.76 1.0
6 vs. 0 0.42 7.43 6.54e8.44 0.56
7 vs. 0 0.14 7.69 6.34e9.34 0.21 1
8þ vs. 0 0.07 10.36 7.96e13.47 0.13 1
Parameters c-Statistic 95% CI c
Age and sex only 0.776 0.772e0.780
þ Comorbidity counta 0.806 0.802e0.810
þ Weighted scoreb 0.823 0.819e0.826
þ Weighted score (9 levels) 0.826 0.822e0.829
Abbreviations: QOF, Quality and Outcomes Framework; HR, hazard ratio
a Only QOF predictors where HR 1.2.
b Fitted as a continuous variable.Specifically, in the United Kingdom, the health service
has checks in place to identify and penalize practices with
unusually high or low prevalence rates, and evidence sug-
gests that the accuracy of disease recording has improved
since the introduction of QOF in 2004 [27].
For researchers using primary care data, our score has two
main benefits compared with the Charlson index, namely (1)
it removes heterogeneous groups of conditions, such as liver
disease and rheumatological conditions, which are likely to
be variably defined, identified, and recorded in primary care
and (2) it removes the need for decisions on selection ofdation data set (n5 335,904)
rlson index Extended QOF score
HR 95% CI % Patients HR 95% CI
1 d 66.2 1 d
1.95 1.84e2.08 13.0 1.56 1.46e1.66
2.98 2.80e3.16 8.4 2.65 2.49e2.81
3.66 3.42e3.92 7.3 3.93 3.71e4.17
4.72 4.33e5.16 2.4 4.88 4.52e5.26
5.66 5.03e6.36 1.5 5.84 5.36e6.37
9.07 8.12e10.13 0.77 7.74 7.07e8.46
1.34 9.60e13.38 0.31 8.11 6.90e9.53
2.95 10.51e15.97 0.26 11.74 10.20e13.52
-Statistic 95% CI c-Statistic 95% CI
0.776 0.772e0.780 0.776 0.772e0.780
0.809 0.806e0.813 0.813 0.810e0.817
0.816 0.812e0.819 0.826 0.822e0.829
0.818 0.814e0.822 0.829 0.825e0.832
; CI, confidence interval.
Table 4. Summary of morbidity scores impact on interpractice variation in mortality
Model No score in model D Standard QOF score D Charlson index D Extended QOF score
Individual level analysis (n5 335,904)a
Age and sex model 0.0330 0.0179 0.0224 0.0172
% Reduction by inclusion of score d 46 32 48
Age, sex, and deprivation model 0.0256 0.0157 0.0199 0.0156
% Reduction by inclusion of score d 39 22 39
Practice level analysis (n5 187)b
Correlation between mean practice score and
standardized mortality rate
d 0.64 0.56 0.64
Base model 0.0258 0.0087 0.0125 0.0082
% Reduction by inclusion of score d 66 51 68
Base model plus deprivation 0.0175 0.0086 0.0116 0.0088
% Reduction by inclusion of score d 51 34 50
Abbreviation: QOF, Quality and Outcomes Framework.
a Uses a hierarchical logistic model to estimate the practice random effect (the estimated variance of the practice intercepts) by inclusion of
individual score to a model with age and sex only (and then repeated with deprivation added). Score has been fitted as a nine-level variable in each
case.
b Uses a random effects meta-regression of log standardized mortality ratio (indirectly standardized for and age and sex) on mean practice score
(per registered patient). Practices are weighted by their within practice standard error, and an estimate of the between practice variance is derived
using restricted maximum likelihood. The analysis is repeated with mean practice deprivation included in the model.
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United Kingdom, however, Read codes are rarely used, but
conditions included in QOF are common chronic conditions,
which are likely to be well identified and recorded in devel-
oped health care systems. This should allow easy mapping to
other health care and coding systems.
A potential weakness of the comparisons of our QOF
scores with the Charlson index is that our approach to devel-
opment and internal validation in a primary care database
will inherently favor the QOF scores. However, as we in-
tended to develop a score suitable for primary care, this does
not invalidate our findings but clearly highlights the need for
caution in applying our score in other countries or data sour-
ces without external validation. Indeed, it is remarkable and
commendable that the Charlson index performs so well in
UK primary care data, given its development in a US second-
ary care setting. This suggests that our score may be simi-
larly generalizable to other populations.
Another potential criticism of our approach is that it as-
sumes that the impact of each of the morbidities is equiva-
lent across different ages for men and women, and we have
only been able to assess performance in patients aged 60
and older. Our analysis suggests that the relative impact
of morbidity on mortality is greater in younger patients.
For example, the HR for cancer in our analyses is 7.1 for
ages 60e74 compared with 2.5 for ages 75þ. This partially
reflects the changing baseline risk of patients without any
morbidity as they age. This may mean that our score per-
forms better in younger age groups, and further validation
is required to confirm performance in younger age groups.
However, as most deaths in United Kingdom (88%) occur
in those older than 60 years, this is unlikely to change
the overall performance.
Our analyses used an aggregated small area measure
of deprivation, the Townsend score, corresponding toapproximately 1,500 residents. Studies in the United King-
dom have demonstrated the acceptability of such measures
as surrogates for individual-level socioeconomic status [28].
We have purposely focused our comparison of perfor-
mance of different scores on measures of discrimination
and explained variation rather than calibration. Both are
important but we do not intend our score to be used as a tool
for individual patient prediction where calibration is essen-
tial. The main use for our score is in adjusting outcomes for
comparison between patient groups, populations, or health
care providers where discrimination is more important than
calibration.4.2. Comparison with other literature
Charlson et al. [4] developed their original score in 1987,
and its use has been widely adopted with almost 7,000 cita-
tions by 2012 [29]. However because the original work was
based on only 559 patients admitted to a New York hospital
during a single month in 1984, attempts have been made re-
cently to revise the original Charlson Index [7,30] or adapt it
to predict health care costs [5]. Variations in the index have
also arisen over time owing to different coding algorithms
for ICD-9 [31e33] and their subsequent translation into
ICD-10 [34e36] and Read codes [9]. Other scores such as
the Elixhauser [23], MACSS [25], or pharmacy-based scores
such as the Chronic Disease Score [37] or RxRisk-V [24]
have been developed; however, variations in performance re-
ported in different populations have resulted in doubts over
the universal application of a single score [12]. To date, the
only morbidity score specifically derived for low-risk ambu-
latory or primary care patients is the Johns Hopkins score,
which is based on US data and relatively complex to imple-
ment [26]. In the United Kingdom, this has been shown to
predict practice variation in prescribing [38] and referrals
Fig. 1. Practice standardized mortality rates plotted against mean
practice standard QOF score. Each bubble represents a single prac-
tice, with the size of each bubble representing the precision of each
estimate (the inverse of the within practice variance). The blue line
represents the fitted regression line. The red dotted lines represent
the 95% confidence limits. QOF, Quality and Outcomes Framework.
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Care provides a simpler classification of clinical activity in
a primary care setting [40], we are not aware of any scores
being derived from it.
Our observation that a shorter list of morbidities still ef-
fectively predicts mortality as well as the original 17 condi-
tions proposed by Charlson is not novel. A recent study using
hospital discharge data from six countries found that a simpli-
fied Charlson index of 12 items predicted in-hospital mortal-
ity as well [7]. Other authors have found that counting
Charlson diagnoses was as effective as aweighted score [41].
We believe ours is the first study to propose using rou-
tinely recorded QOF data to develop a bespoke morbidity
score for primary care. Two recent studies of a similar
UK primary care database have counted QOF diseases to
define multimorbidity, and related it to consultations [14]
and costs [42]. The former found that 16% of adults with
two or more conditions accounted for 32% of total consul-
tations in 2005e2008, and that the number of QOF condi-
tions accounted for the much of the relationship between
higher consultation rates and deprivation [14]. The latter
found that a simple count of QOF conditions was the most
efficient approach for predicting patient costs [42].
4.3. Implications
There are a number of key differences between our score
and the Charlson index, which reflect their respective devel-
opment in primary and secondary care. The QOF scores in-
clude conditions that are more commonly seen in primary
care or outpatient settings such as atrial fibrillation, epi-
lepsy, and severe mental illness, which are not part of the
Charlson index. However, our QOF score excludes asthma,
which is common, but not a strong predictor of mortality in
the general population.The Charlson index performs remarkably well in UK pri-
mary care data [9], and its continued use in research using
primary care data is valid. However, our standard QOF score
has a number of characteristics that may make it an attractive
alternative in research and service settings. Crucially, the
definitions of conditions included in QOF are nationally de-
fined, agreed, and updated, whereas implementation of the
Charlson index requires decisions by individual researchers
on choice of appropriate codes, which can cause different
translations [36]. Our finding that the QOF scores accounted
for more interpractice variability in mortality suggest that
use of our QOF score will be effective in reducing variation
in outcome measures between service providers attributable
to case mix. Although developed using mortality as the main
outcome, our score offers the potential for comorbidity ad-
justment or prediction for a range of health and health care
outcomes, such as hospital admission [43] or adverse drug
reactions [44], in a similar manner to current use of the
Charlson index.
For the United Kingdom, a key benefit from this work is
the potential for a summary morbidity score for all practices,
which can be used for risk adjustment in national analyses
and does not rely on access to individual patient data, which
other morbidity scores would require. A mean practice QOF
score could be easily collected from practices as part of ex-
isting data collection for implementation of QOF. In our
sample of older patients, such amean practice QOF score ac-
counted for a third of between practice variations in ageesex
standardized mortality. Furthermore, although deprivation is
easily accounted for in the analysis of primary care data us-
ing area-based measures, our analysis demonstrates that this
cannot substitute for adjustment for morbidity, and that tak-
ing account of morbidity is more important than deprivation
in comparisons between practices.
There has been a desire to compare outcomes, including
mortality, between individual primary care providers for
a number of years, but other authors have identified a num-
ber of methodological barriers, including adequate adjust-
ment for case mix and potentially large numbers of false
alarms [45,46]. A simple effective morbidity score will help
address these concerns by reducing variation owing to case
mix. Ensuring fair morbidity-adjusted comparisons be-
tween primary care providers will become more important
as health systems encourage competition between pro-
viders. Our standard QOF score provides a straightforward
tool for comparing mortality and other outcomes between
populations either as an aggregate anonymized measure at
practice level or using the score for indirect standardization
in a similar way to age and sex.5. Conclusions
A simple morbidity score based on common chronic
conditions recorded in primary care is highly predictive
of 1-year mortality in an older UK population, offering
443I.M. Carey et al. / Journal of Clinical Epidemiology 66 (2013) 436e444the potential for improving risk-adjusted comparisons of
performance and outcomes in primary and ambulatory care
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